Tango Therapeutics Inc
(NAS:TNGX)
$
9.982
0.31 (3.2%)
Market Cap: 1.07 Bil
Enterprise Value: 752.88 Mil
PE Ratio: 0
PB Ratio: 4.18
GF Score: 52/100 
Tango Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023 / 04:15PM GMT
Release Date Price:
$3.33
(-2.92%)
Kevin Strang
(Trades, Portfolio) LLC - Analyst
Hi, everyone. My name is Kevin Strang, one of the biotech associates here at Jefferies. It's my pleasure today to introduce Adam Crystal, the President and Head of R&D at Tango Therapeutics.
Adam Crystal
Tango Therapeutics, Inc. - President & Head, Research and Development
Thanks so much for the introduction. And thank you for your attention today, and the opportunity to introduce you to Tango. My name is Adam Crystal. I am the head of R&D at Tango. Very excited today to really give you a summary into the founding of Tango. But then go into some more depth on recent proof of mechanism data, which we have put out there for our lead program, the MTA-cooperative PRMT5 inhibitor.
So Tango
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers